Edition:
United States

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

15.12USD
3:59pm EST
Change (% chg)

$0.48 (+3.28%)
Prev Close
$14.64
Open
$14.71
Day's High
$15.40
Day's Low
$14.59
Volume
23,220
Avg. Vol
32,189
52-wk High
$18.46
52-wk Low
$10.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.504
Jun '17 0.00 -0.587
Mar '17 0.00 -0.355
FY 2016 Dec '16 0.00 -0.479
Sep '16 0.00 -0.460
Jun '16 0.00 -0.633
Mar '16 0.00 -0.390
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 5 2.00 10.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.60 -0.52 -0.68 --
Quarter Ending Jun-18 2 -0.62 -0.52 -0.71 --
Year Ending Dec-18 5 -2.18 -1.72 -2.50 -2.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.98 34.59
P/E High - Last 5 Yrs. -- 40.44 45.93
P/E Low - Last 5 Yrs. -- 23.35 24.19
Beta -- 0.82 0.81
Price to Sales (TTM) -- 5.68 8.08
Price to Book (MRQ) 3.01 4.36 5.24
Price to Tangible Book (MRQ) 3.01 4.90 6.43
Price to Cash Flow (TTM) -- 22.95 25.98
% Owned Institutions 91.65 1.24 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.60 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.22 5.21
Payout Ratio(TTM) -- 43.76 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.49 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 6.41 7.61
Sales - 5 Yr. Growth Rate -- 9.87 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.51 16.81 18.78
EPS (TTM) vs TTM 1 Yr. Ago -6.30 -- --
EPS - 5 Yr. Growth Rate -- 10.44 11.55
Capital Spending - 5 Yr. Growth Rate 62.54 14.57 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.40 2.42
Current Ratio (MRQ) 17.23 3.34 3.39
LT Debt to Equity (MRQ) 0.00 9.39 12.18
Total Debt to Equity (MRQ) 0.00 12.62 15.60
Interest Coverage (TTM) -- 44.43 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.20 54.74
Gross Margin - 5 Yr. Avg. -- 52.46 52.50
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.43 14.67
Operating Margin (TTM) -- 11.85 4.40
Operating Margin - 5 Yr. Avg. -- 14.25 9.99
Pre-Tax Margin (TTM) -- 12.22 5.14
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 10.24
Net Profit Margin (TTM) -- 8.65 1.86
Net Profit Margin - 5 Yr. Avg. -- 10.86 6.55
Effective Tax Rate (TTM) -- 22.18 21.87
Effective Tax Rate - 5 Yr. Avg. -- 23.50 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 924,143,029 823,803,020
Net Income/Employee (TTM) -1,188,395 108,124,219 96,327,335
Receivable Turnover (TTM) -- 5.35 5.44
Inventory Turnover (TTM) -- 2.62 3.52
Asset Turnover (TTM) 0.00 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.62 11.21 10.76
Return on Assets - 5 Yr. Avg. -38.97 12.69 12.05
Return on Investment (TTM) -33.44 14.12 13.67
Return on Investment - 5 Yr. Avg. -41.94 16.62 15.78
Return on Equity (TTM) -33.52 15.72 15.40
Return on Equity - 5 Yr. Avg. -136.44 17.74 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -13.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aquinox Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.69%
# of Holders: 59
Total Shares Held: 21,514,933
3 Mo. Net Change: -380,150
# New Positions: 15
# Closed Positions: 10
# Increased Positions: 33
# Reduced Positions: 19
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.